4.7 Article

Novel K-Ras G12C Switch-II Covalent Binders Destabilize Ras and Accelerate Nucleotide Exchange

期刊

出版社

AMER CHEMICAL SOC
DOI: 10.1021/acs.jcim.7b00399

关键词

-

资金

  1. National Institutes of Health [R01 (5R01CA190408)]
  2. F30 Kirschstein-NRSA [1F30CA214015]
  3. Stand Up To Cancer American Cancer Society Lung Cancer Dream Team Translational Research Grant [SU2C-AACR-DT17-15]
  4. American Association for Cancer Research
  5. Israel Science Foundation [1097/16]
  6. Rising Tide Foundation
  7. Israel Cancer Research Foundation
  8. CIHR new investigator program
  9. Natural Sciences and Engineering Research Council of Canada [NSERC-2014-05218]
  10. National Institutes of Health Grant [5R01CA172667]
  11. scientific partner of SU2C

向作者/读者索取更多资源

The success of targeted covalent inhibitors in the global pharmaceutical industry has led to a resurgence of covalent drug discovery. However, covalent inhibitor design for flexible binding sites remains a difficult task due to a lack of methodological development. Here, we compared covalent docking to empirical electrophile screening against the highly dynamic target K-Ras(G12C). While the overall hit rate of both methods was comparable, we were able to rapidly progress a docking hit to a potent irreversible covalent binder that modifies the inactive, GDP-bound state of K-Ras(G12C). Hydrogen-deuterium exchange mass spectrometry was used to probe the protein dynamics of compound binding to the switch-II pocket and subsequent destabilization of the nucleotide-binding region. SOS-mediated nucleotide exchange assays showed that, contrary to prior switch-II pocket inhibitors, these new compounds appear to accelerate nucleotide exchange. This study highlights the efficiency of covalent docking as a tool for the discovery of chemically novel hits against challenging targets.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据